You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Nondestructive Concrete Characterization System

    SBC: NLA DIAGNOSTICS LLC            Topic: A12aT013

    During covert operations, the U.S. Army may be required to breach a concrete structure using a controlled explosion. When choosing the most effective charge size and placement, it is vital to perform a rapid field assessment of the material and structural properties of the target structure. However, recent advances in manufacturing high strength concrete materials (such as Ductal) may increase the ...

    STTR Phase I 2013 Department of DefenseArmy
  2. Highly Efficient Engineered Obscurant Nanomaterials

    SBC: LYNNTECH INC.            Topic: A12aT024

    Obscurant materials are used by the Army to protect both the soldier as well as military physical assets. Several obscuration systems have been developed over the years to defeat threats in all areas of the electromagnetic spectrum. Current obscurant materials typically consist of off-the-shelf or processed metal particles or flakes in which key properties such as particle size and aspect ratio ...

    STTR Phase I 2013 Department of DefenseArmy
  3. Nondestructive Concrete Characterization System

    SBC: FDH Engineering Inc.            Topic: A12aT013

    With the advent of very high strength concrete, such as that manufactured by LaFarge, calculations that have been used historically to determine the explosive content needed to breach concrete structures have been compromised. As a result of this and other mission critical issues, the Army has indentified a need to develop a man-portable device capable of estimating the thickness and strength of ...

    STTR Phase I 2013 Department of DefenseArmy
  4. Construction of 3-D Terrain Models from BIG Data Sets

    SBC: Scalable Algorithmics USA            Topic: A13AT005

    The objective of this proposal is to design, analyze, and implement scalable algorithms for analysis-driven construction of high-resolution 3D terrain models from BIG terrain data sets, and to build a software infrastructure for making analysis-prepared terrain models available to data consumers on multiple platforms. Analysis-driven modeling means that the construction of the model is influence ...

    STTR Phase I 2013 Department of DefenseArmy
  5. Solar Blind MgZnO Photodetectors

    SBC: AGNITRON TECHNOLOGY, INC.            Topic: A13AT006

    This Phase I program is focused on enhancement of the performance of MgZnO based solar blind detectors. MgZnO alloys have superior optoelectronic properties with bandgaps suitable for solar blind detection. Issues related to doping and miscibility will be addressed. This will involve the use of advanced MOCVD and MBE growth techniques and consideration of both Schottky and p-n junction devices. No ...

    STTR Phase I 2013 Department of DefenseArmy
  6. Inhibition of retinoic acid metabolism for reversal of cognitive deficits in AD

    SBC: DERMAXON LLC            Topic: NIA

    DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is a progressive and ultimately fatal neurodegenerative disease that affects more than five million people in the USA. Currently there is no cure for AD. Available medicines are aimed only at temporarily reducing symptoms and slowing down the progression of the disease. While many new compounds have been developed to treat AD, they ...

    STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  7. Osteochondral tissue repair in an ovine model using a 3D woven poly (e-caprolacto

    SBC: Cytex Therapeutics, Inc.            Topic: NIA

    DESCRIPTION (provided by applicant): Standard microfracture is a first-line, widely used and cost-effective surgical technique for repairing damaged articular cartilage, but, it is limited by decreased long-term efficacy and limited applicability in largerlesions. This leads to a burgeoning economic burden associated with primary and follow-up treatment costs, estimated at more than 40 billion dol ...

    STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  8. Controlling mechanical signal transduction to treat osteoarthritis

    SBC: Cytex Therapeutics, Inc.            Topic: NIA

    DESCRIPTION (provided by applicant): Controlling mechanical signal transduction to treat osteoarthritis Abstract The TRPV4 calcium (Ca++) permeable ion channel has been shown to be expressed and functional in chondrocytes, the cells responsible for the maintenance of cartilage in weight-bearing joints. Trauma of joints with subsequent damage of cartilage, as well as chronically increased joint loa ...

    STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  9. Evaluation of a new class of molecules for treating MRSA infective endocarditis

    SBC: AGILE SCIENCES, INC.            Topic: NIAID

    DESCRIPTION (provided by applicant): Patients with infective endocarditis (IE) have a poor prognosis with one third of the patients succumbing to the infection within the first year. Treatments for endocarditis involve antibiotic therapy and/or surgery that cost upwards of 100,000 per patient; however, many cases do not respond to the antibiotic treatment and surgery poses high risks. Cases of en ...

    STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  10. Targeting c-Myc and Akt with PP2A reactivation therapy for the treatment of breas

    SBC: ONCOTIDE PHARMACEUTICALS, INC.            Topic: NCI

    DESCRIPTION (provided by applicant): Each year in the United States over 270,000 women will be diagnosed with breast cancer and over 40,000 will die from the disease. While multiple forms of breast cancer exist, a common theme in most of the forms involvesaberrations in signal transduction pathways that lead to inhibition of the programmed cell death process known as apoptosis. Apoptosis is a care ...

    STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government